Semax 10MG
Find your strength. Choose your bundle.
182 in stock
Earn up to $2.95 back on this itemLazarus Pass · 1–5% store credit + free shipping protection · A$19.95/moA closer
look.
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10).
In neurobiological research it is used as a reference compound for studying neuropeptide signalling and neurotrophic pathways in model systems.
Research details & references
Last reviewed:
Lazarus Labs supplies Semax in Australia as a 10 mg lyophilised reference material at ≥ 99 % purity, with a certificate of analysis for every lot. For research use only — not for human or veterinary use.
What is Semax?
Research context
Semax is a modified ACTH(4–10) fragment studied in neuropeptide and neurotrophic-signalling research, including pathways associated with BDNF in study models. Laboratories use it as a stable reference material for that work. It is supplied strictly for laboratory research.
Specifications
- Presentation: 10 mg per vial
- Purity: ≥ 99 %, confirmed by HPLC and LC-MS
- Form: white lyophilised powder
- Solubility: readily soluble in water (H₂O)
- Testing: every batch independently tested by Janoshik (HPLC + LC-MS)
- Documentation: third-party certificate of analysis per lot
- Intended use: in-vitro and laboratory research only
Quality & documentation
Every lot of Semax is independently tested by Janoshik Analytical, with a certificate of analysis reporting HPLC purity and LC-MS identity for your exact batch.
Handling & storage
Store sealed and dry at 2–8 °C. After reconstitution, keep refrigerated and follow your laboratory’s own handling and stability procedures. Semax is supplied for research use only and is not for human or veterinary use.
Dispatch & supply in Australia
Semax ships from within Australia with tracked delivery, and every order includes the matching certificate of analysis.
Read the citation-backed research overview →
Cited research
- Dolotov OV, et al Brain Research. 2006. PMID: 16996037.
- Dolotov OV, et al Journal of Neurochemistry. 2006. PMID: 16635254.
- Inozemtseva LS, et al European Journal of Pharmacology. 2024. PMID: 39442746.
- Radchenko AI, et al Acta Naturae. 2025. PMID: 41479572.
Primary literature, verified against PubMed. Cited for scientific reference only — no human-use indication is implied.
The finer
details.
Check the product format, available strengths and intended use.
- Product
- Semax 10MG
- Intended use
- Laboratory research only
- Documentation
- See COA tab for strength and batch reports
Read the report.
Know the batch.
Compare the product, strength and batch on your vial with the original laboratory document.
Supplier batch report
- Batch
- LL-SEMAX-0125
- Tested
- 2026-02-05
- Reported purity
- 99.566%
Reports identify tested batches. The available reports do not establish which batch will be dispatched with your order.
WA dispatch.
Tracked delivery.
Orders are dispatched from Western Australia with tracking. Check the selected product's availability and any pre-order notice before ordering.
Pre-order items follow their stated dispatch estimate. Orders containing pre-order items ship together once everything is available.
Shipping details →



